). The variable amino acids (indicated as "X") were representatives of every a quenching Dabcyl group and a fluorescein group coupled to amino acid two and eight, respectively. The chemical group of amino acids. With the exception of the third amino acid position, the variable amino acids quencher efficiently absorbs emission of the nearby fluorescein group, and fluorescence will only be detected were positioned outside the quencher-fluorophore box (indicated by "K" and "C"). Peptide degradation always when amino acids two and eight are separated in space as the result of peptidase activity ( Figure 1A Table 1 ). Equal expression of the minigen was controlled through GFP expression from the same transcript. Activation of the influenza M epitope-specific, HLA-A2-restricted T cell clone was measured by IFN secretion after o/n culture at different effector/target cell ratios. The experiments were performed in triplicate, and means ( SEM) are indicated.
sion increases the half-life of the reporter peptide, which the 9-mer peptide was no substrate for proteasomes (data not shown). This agrees with the observation that is in line with observations that carboxy peptidase activity is absent in the cytoplasm. Beyond 15 amino acids, N-terminally protected peptides were stable in vivo. Apparently, small peptides are digested in the cytoplasm peptides become the exclusive substrate for TPPII that removes N-terminal sequences, including nine potential exclusively by aminopeptidases and not by carboxy or endopeptidases . amino acid epitopes. However, epitopes located at the C terminus of these larger peptides are presented less efficiently suggesting that TPPII can generate but also Sequence Specificity of the Intracellular Peptidase Pool destroy epitopes. We show that TPPII plays an important role in antigen processing, as most proteasomal prodSome aminopeptidases like LAP have defined substrate specificities (Turzynski and Mentlein, 1990). Variation in ucts require further processing by TPPII for MHC class I presentation. As a consequence, peptide generation the amino acid sequence of the reporter peptide may therefore affect the degradation rate in vivo. This is imfor MHC class I is severely hampered when TPPII activity is inhibited.
portant since an increased peptide half-life should theoretically correlate with a better chance to reach the ER lumen, resulting in an improved class I presentation. To Results examine whether the cytoplasmic peptidases collectively show sequence selectivity, we systematically varAminopeptidases Degrade Peptides In Vivo An internally quenched 9-mer peptide was used to deied amino acids positioned at the first, second, third, or last position within an internally quenched reporter tect peptidase activity in vivo. The quenched reporter peptide (T[K-Dabcyl]NKTER[C-Fluorescein]Y) contains peptide sequence (Figures 2A-2D ). The variable amino acids (indicated as "X") were representatives of every a quenching Dabcyl group and a fluorescein group coupled to amino acid two and eight, respectively. The chemical group of amino acids. With the exception of the third amino acid position, the variable amino acids quencher efficiently absorbs emission of the nearby fluorescein group, and fluorescence will only be detected were positioned outside the quencher-fluorophore box (indicated by "K" and "C"). Peptide degradation always when amino acids two and eight are separated in space as the result of peptidase activity ( Figure 1A ). As shown started immediately after its introduction in living cells by microinjection and went to completion. Surprisingly, before , fluorescence appeared almost immediately after microinjection of the quenched rethe different amino acids hardly affected the peptide half-life (Figures 2A-2D , the t1/2 of full peptide degradaporter peptide into living Mel JuSo cells, and degradation went to completion with a half-life of a few seconds tion is plotted), indicating that the collective pool of peptidases is able to efficiently degrade every peptide (t1/2 4.1 0.9 s; Figure 1B ). The peptide was degraded exclusively by aminopeptidases, as blocking the free N sequence almost irrespective of the type of amino acid at these positions. The differences in peptide half-life terminus of the peptide by a protective group inhibited degradation . Treatment of cells with of the tested combinations are within a factor 2. The rate of degradation decreased only when the N-terminal lactacystin to inhibit proteasomal degradation had no effect on the rapid rate of degradation, indicating that amino acid was replaced by an unnatural D amino acid amino acid is not cleavable. In summary, the heterogeneous pool of cytoplasmic peptidases in cells efficiently digests peptides with no major sequence selectivity unless stereoisomeric D amino acids are introduced.
Cytoplasmic Peptidase Activity, Substrate Length, and Antigen Presentation by MHC Class I Since the second amino acid of the original reporter peptide contained the quencher group, we repositioned the quencher molecule to the third position and extended the N terminus by one additional amino acid to examine the effect of amino acid variations at the second position. While again no major effect of the sequence variation was observed, the half-life of the reporter peptide increased ( Figure 2D ). Apparently the presence of two additional N-terminal amino acids reduced proteolytic access to the quencher-fluorophore reporter. To examine the relationship between peptide length and in vivo half-life, the reporter peptide was extended either at the C or N terminus with a repeat of amino acids again representing the various chemical groups ( Figure  3 ). When the C terminus was extended with three, six, or twelve amino acids, no increase in the half-life of the reporter sequence was observed ( Figure 3A) . Even a further extension by 18 amino acids did not increase the short half-life of the N-terminal reporter sequence in vivo. Apparently, trimming aminopeptidases are degrading the first N-terminal amino acids of the reporter sequence at similar rates, irrespective of the length of the C terminus. If correct, then addition of amino acids at the N terminus should increase the reporter's half-life, as trimming aminopeptidases have to remove more amino acids before encountering the internally quenched reporter. Indeed, extending the N terminus up to three additional amino acids increased the half-life of the reporter sequence ( Figure 3B) . Surprisingly, further extension by 6, 11, or 18 additional amino acids did not lead to a further increase in half-life. To exclude that the presence of one or more proline residues in the N-terminal extension would influence aminopeptidase activity (Yellen-Shaw et al., 1997), we replaced these residues for threonine residues. The half-life of these model peptides was not affected by the proline to threonine exchange (data not shown). Despite more N-terminal amino acids, the halflife of the reporter sequence remains similar when pre- to the sequences used in the model peptides tested in Figures 3A and 3B . The various minigenes were cloned in a vector upstream of an IRES sequence followed isomer ( Figures 1B and 2A) . This suggests that a large portion of the collective peptidase activities cleaves beby GFP to ensure cotranscriptional expression. These constructs were stably expressed in HLA-A2-expressing tween the first and second amino acid, as the peptide bond between the N-terminal D and the following L Mel JuSo cells and sorted for equal GFP expression Table 1 ). Equal expression of the minigen was controlled through GFP expression from the same transcript. Activation of the influenza M epitope-specific, HLA-A2-restricted T cell clone was measured by IFN secretion after o/n culture at different effector/target cell ratios. The experiments were performed in triplicate, and means ( SEM) are indicated.
before determining the T cell response. The influenza Moreover, extending the N terminus with 15 amino acids epitope with a C-terminal extension of one or three resulted in a reduced presentation of the influenza epiamino acids were not presented. Mel JuSo cells are tope ( Figure 3C ). Since the sequence of the shorter exapparently unable to generate the properly sized 9-mer tensions is repeated in the longest sequence, these data influenza epitope in the absence of carboxypeptidase indicate that N-terminal extensions do not necessarily activity . Contrary to what may be improve antigen presentation. The longest extension expected, extending the N terminus of the influenza generates a minigene product of 28 amino acids and epitope with one or five amino acids did not increase may be a substrate for the previously observed peptipresentation of influenza M epitope to specific T cells. dase activity that is active on larger fragments and may generate, though less efficiently, this specific epitope. To investigate the role of this peptidase in more detail, Figure 3B) . Surprisingly, a corresponding 18-mer peptide with the reporter sequence at the C termito the medium was sufficient to completely inhibit the degradation of the 20-mer peptide in living cells. Since nus was degraded almost as fast as the 27-mer with the centered reporter sequence, suggesting that they cells were always microinjected under serum-free conditions, the effect of serum on the stability of butabindide are not substrates for trimming amino peptidases but that the 18-and 27-mer are possibly targeted by an was tested. Even small amounts of fetal calf serum prevented the inhibitory effect of butabindide ( Figure 5A ). endopeptidase that cleaves these peptides into large pieces, thereby separating the quencher and fluoroTo our knowledge, butabindide has not been successfully used in in vivo experiments before to inhibit peptide phore. To examine the requirements for an unmodified N terminus, the 27-mer peptide with the reporter sedegradation by TPPII, which may be explained by the apparent inhibitory effect of serum on butabindide treatquence in the middle was modified by either placing one or two D amino acids at the N terminus or by blocking the ment. To test the stability of butabindide in our experimental system, the 20-mer internally quenched peptide N terminus ( Figure 4B ). Replacing the first two amino acids by D amino acids did not influence the half-life of was microinjected in cells (in serum-free medium) at various times after addition of the inhibitor at 10 4 M. the reporter sequence. However, blocking the free N terminus prevented degradation of the 27-mer peptide Complete inhibition of peptide degradation was observed until 1.5 hr after butabindide addition, after in vivo. These data suggest that long peptides are handled by distinct peptidases that can remove larger which peptide degradation was recovering (data not shown). pieces but require a free N terminus.
We subsequently measured the degradation rates of peptides, varying in size between 9 and 27 amino acids, Long Peptides Are Selectively Degraded by TPPII Since proteasomal activity may be involved in degrading by microinjecting these in cells cultured in the presence or absence of butabindide. The rate of degradation for large peptide fragments, we measured peptide degradation in the presence of proteasome inhibitor, but no peptides up to 15 amino acids was not significantly affected by inhibition of TPPII, although the N-terminally change in peptide half-life was observed (data not shown). Another candidate might be the large peptidase extended 15-mer peptide was degraded less efficiently under these conditions. Presentation of the 14-mer influcomplex TPPII, which has reported exo-and endopeptidase activities (Geier et al., 1999) . To test whether TPPII enza epitope expressed from minigenes was not affected when cells were first stripped to dissociate most was the peptidase specialized in the degradation of the long peptides, the inhibitor butabindide was used. Busurface class I molecules by acid wash and cultured for 16 hr in the absence or presence of butabindide followed dependent on TPPII activity ( Figure 5C ) irrespective of the position of the reporter sequence, since no degradaby the CTL assay ( Figure 5B ). This indicates that butabindide treatment did not inhibit synthesis, assembly, tion was observed (D.N.O.) in the presence of butabindide. Apparently, peptides longer than 15 amino acids and transport of MHC class I molecules, nor presentation of small peptides. However, the degradation of pepcan only be efficiently degraded by TPPII in vivo. To test whether butabindide affected proteasome tides larger than 15 amino acids appeared to be critically peptides equally. Apparently, TPPII has two activities: one activity that Here, we show that variation of amino acids at the removes small fragments from the N terminus and a first, second, third, or last position does not result in second but slower activity that generates larger fragmajor differences in the half-life of introduced peptides.
ments. Since a fragment containing eight D amino acids
Although the quencher and/or fluorophore might affect has to be cleaved after the following L amino acid, TPPII the ability of some peptidases to hydrolyse the reporter is apparently able to generate 9-mer fragments (or peptide, our data suggests that the heterogeneous pool longer).
of cytoplasmic peptidases destroys small peptides rapTo determine the relevance of TPPII in peptide generaidly but fairly irrespective of amino acid sequence. Since tion for MHC class I molecules, both Mel JuSo cells and peptides are degraded exclusively by aminopeptidases freshly isolated peripheral blood lymphocytes (PBLs) , additional N-terminal amino acids were stripped to dissociate most surface class I moleshould increase the half-life of an antigen, as has been cules by acid wash. The cells were subsequently culsuggested previously (Cascio et al., 2001 ). The half-life tured in the presence or absence of the proteasome of the 9-mer reporter sequence increases from 4 to 30 s inhibitor lactacystin, butabindide, or a combination of when three additional amino acids are present at the N the two inhibitors, all under serum-free conditions. Buterminus. Apparently, every additional amino acid intabindide was readded every hour. After 4 hr, MHC class creases the reporter's half-life with around 6 s until the I molecules at the cell surface were labeled with the peptide becomes longer than 15 amino acids. Still, when antibody W6/32, followed by FACS analysis ( Figure 7B ). minigene constructs with N-terminal extensions are exSurprisingly, butabindide treatment resulted in a similar pressed, no increased level of influenza M-epitope prereduction in cell surface MHC class I as treatment with sentation is observed. In fact, a long N-terminal extenproteasome inhibitor, while the combination of the two sion (15 additional amino acids) results in decreased inhibitors only had a marginal additive effect. Identical levels of antigen presentation. This may be surprising, effects were obtained with the less specific TPPII inhibisince the short N-terminal sequences were included in tor AAF-CMK (data not shown). Given the substrate the long N-terminal sequence, but it suggests that the specificity of TPPII, our data suggests that a major porantigenic sequence within the long peptide is partially tion of proteasomal products consists of long peptides degraded by an endopeptidase. Extending the total (over 15 amino acids) that are subsequently targeted by length of the reporter peptide beyond 15 amino acids TPPII. Since these peptides will be too long for MHC does not reduce the rate of degradation any further, class I loading, TPPII will act as a crucial intermediate which suggests that these peptides were handled differbetween proteasomes, cytoplasmic or ER peptidases, ently from shorter peptides by the cytoplasmic aminoand MHC class I molecules.
peptidases. Extending the C terminus of the NP-epitope prevents presentation by MHC class I, which confirms Discussion the observed absence of cytoplasmic carboxypeptidase activities . The efficiency of antigen presentation by MHC class I
The enzyme involved in long peptide degradation should display aminopeptidase activity, since blocking molecules is amazingly low, since more than 99% of the and presentation by MHC class I molecules. Our data for the N terminus but also fragments of nine amino suggests the following sequence of events to occur for a acids or more (albeit less efficient). This corresponds successful class I response ( Figure 7C ). The proteasome to the reported in vitro activities of TPPII, where TPPII digests proteins mainly in fragments larger than 15 requires a free N terminus and preferably removes fragamino acids. TPPII trims these peptides into smaller ments of two to three amino acids (Tomkinson, 1999) .
fragments that may include proper class I binding pepIt is unclear whether there is a maximal size for the tides. A variety of peptidases (including TOP, LAP, and peptide substrates for TPPII, but it may cleave at various ERAAP) then continues the digestion into even smaller positions within a substrate, since a reporter sequence products. These three proteolytic steps act in a process in the middle of a 27-mer peptide is degraded as rapidly degrading proteins down to small fragments and amino as an N-terminally positioned reporter. The observed acids, occasionally generating a class I binding peptides differences in half-life of C-terminally positioned reportinstead of destroying it. In every step, peptides may ers in peptides longer than 16 amino acids may be the escape further trimming by cytoplasmic peptidase activresult of cleavage by TPPII, resulting in differently sized ity by being transported into the ER by TAP for considerfragments containing the reporter sequence that need ation by ERAAP and MHC class I. Most peptides will subsequent degradation by aminopeptidases. How however be degraded into single amino acids. TPPII decides to remove small or long fragments is unclear. One possibility is that additional complexes regu- molecules by following cell surface reappearance of Peptides were quantified by their red appearance (Dabcyl) using
